STAT3 Inhibits Autocrine IFN Signaling in Type I Conventional Dendritic Cells is a research paper published in The Journal of Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cancer Prevention and Research Institute of Texas
Grant: RP170067
Cancer Prevention and Research Institute of Texas
Grant: RP210028
HHS | National Institutes of Health
Grant: R01AI109294
HHS | National Institutes of Health
Grant: R01AI133822
NCI NIH HHS
Grant: P30 CA016672
NIAID NIH HHS
Grant: R56 AI109294
NIGMS NIH HHS
Grant: T32 GM135066
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 5R01AI133822-03
Defining Protective Responses in Hematopoietic Cells Mediated by STAT3 Anti-Inflammatory Activity
FWCI
0.45
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals